Glucose-dependent insulinotropic polypeptide receptor deficiency leads to modifications of trabecular bone volume and quality in mice

Bone

Volumn 53, Issue 1, 2013, Pages 221-230

  Gaudin Audrain, Christine ^a   Irwin, Nigel ^b   Mansur, Sity ^b   Flatt, Peter R ^b   Thorens, Bernard ^c   Baslé, Michel ^a   Chappard, Daniel ^a   Mabilleau, Guillaume ^a  

^a UNIV Angers   (France)

^b UNIVERSITY OF ULSTER   (United Kingdom)

^c UNIVERSITY OF LAUSANNE   (Switzerland)

Author keywords

Adipokine; Bone microarchitecture; Bone quality; Glucose dependent insulinotropic polypeptide; Incretin

Indexed keywords

ADIPOCYTOKINE; COLLAGEN; GASTRIC INHIBITORY POLYPEPTIDE; GLUCOSE DEPENDENT INSULINOTROPIC POLYPEPTIDE RECEPTOR; RECEPTOR PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOMECHANICS; BONE DENSITY; BONE MASS; BONE MATRIX; BONE MATURATION; BONE QUALITY; BONE REMODELING; BONE STRUCTURE; CELL COUNT; CONTROLLED STUDY; FEMALE; MALE; MICRO-COMPUTED TOMOGRAPHY; MORPHOMETRICS; MOUSE; MUSCULOSKELETAL SYSTEM PARAMETERS; NONHUMAN; OSSIFICATION; OSTEOCLAST; PROTEIN CROSS LINKING; PROTEIN DEPLETION; PROTEIN EXPRESSION; TRABECULAR BONE;

ADIPOKINES; ANIMALS; BODY WEIGHT; CELL DIFFERENTIATION; FEMALE; GLUCOSE; MALE; MICE; MICE, KNOCKOUT; ORGAN SIZE; OSTEOCLASTS; RECEPTORS, GASTROINTESTINAL HORMONE; SPECTROSCOPY, FOURIER TRANSFORM INFRARED; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84872180477     PISSN: 87563282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bone.2012.11.039     Document Type: Article

References (43)

1. Elnenaei M.O., Musto R., Alaghband-Zadeh J., Moniz C., Le Roux C.W. Postprandial bone turnover is independent of calories above 250kcal. Ann Clin Biochem 2010, 47:318-320.
2. Henriksen D.B., Alexandersen P., Bjarnason N.H., Vilsboll T., Hartmann B., Henriksen E.E., et al. Role of gastrointestinal hormones in postprandial reduction of bone resorption. J Bone Miner Res 2003, 18:2180-2189.
3. Andersen D.K., Elahi D., Brown J.C., Tobin J.D., Andres R. Oral glucose augmentation of insulin secretion. Interactions of gastric inhibitory polypeptide with ambient glucose and insulin levels. J Clin Invest 1978, 62:152-161.
4. Schirra J., Katschinski M., Weidmann C., Schafer T., Wank U., Arnold R., et al. Gastric emptying and release of incretin hormones after glucose ingestion in humans. J Clin Invest 1996, 97:92-103.
5. Varner A.A., Isenberg J.I., Elashoff J.D., Lamers C.B., Maxwell V., Shulkes A.A. Effect of intravenous lipid on gastric acid secretion stimulated by intravenous amino acids. Gastroenterology 1980, 79:873-876.
6. Baggio L.L., Drucker D.J. Biology of incretins: GLP-1 and GIP. Gastroenterology 2007, 132:2131-2157.
7. Irwin N., Flatt P.R. Therapeutic potential for GIP receptor agonists and antagonists. Best Pract Res Clin Endocrinol Metab 2009, 23:499-512.
8. Bollag R.J., Zhong Q., Phillips P., Min L., Zhong L., Cameron R., et al. Osteoblast-derived cells express functional glucose-dependent insulinotropic peptide receptors. Endocrinology 2000, 141:1228-1235.
9. Pacheco-Pantoja E.L., Ranganath L.R., Gallagher J.A., Wilson P.J., Fraser W.D. Receptors and effects of gut hormones in three osteoblastic cell lines. BMC Physiol 2011, 11:12.
10. Bollag R.J., Zhong Q., Ding K.H., Phillips P., Zhong L., Qin F., et al. Glucose-dependent insulinotropic peptide is an integrative hormone with osteotropic effects. Mol Cell Endocrinol 2001, 177:35-41.
11. Zhong Q., Ding K.H., Mulloy A.L., Bollag R.J., Isales C.M. Glucose-dependent insulinotropic peptide stimulates proliferation and TGF-beta release from MG-63 cells. Peptides 2003, 24:611-616.
12. Zhong Q., Itokawa T., Sridhar S., Ding K.H., Xie D., Kang B., et al. Effects of glucose-dependent insulinotropic peptide on osteoclast function. Am J Physiol Endocrinol Metab 2007, 292:E543-E548.
13. Tsukiyama K., Yamada Y., Yamada C., Harada N., Kawasaki Y., Ogura M., et al. Gastric inhibitory polypeptide as an endogenous factor promoting new bone formation after food ingestion. Mol Endocrinol 2006, 20:1644-1651.
14. Xie D., Cheng H., Hamrick M., Zhong Q., Ding K.H., Correa D., et al. Glucose-dependent insulinotropic polypeptide receptor knockout mice have altered bone turnover. Bone 2005, 37:759-769.
15. Xie D., Zhong Q., Ding K.H., Cheng H., Williams S., Correa D., et al. Glucose-dependent insulinotropic peptide-overexpressing transgenic mice have increased bone mass. Bone 2007, 40:1352-1360.
16. Chappard D., Basle M.F., Legrand E., Audran M. New laboratory tools in the assessment of bone quality. Osteoporos Int 2011, 22:2225-2240.
17. Preitner F., Ibberson M., Franklin I., Binnert C., Pende M., Gjinovci A., et al. Gluco-incretins control insulin secretion at multiple levels as revealed in mice lacking GLP-1 and GIP receptors. J Clin Invest 2004, 113:635-645.
18. Blouin S., Basle M.F., Chappard D. Interactions between microenvironment and cancer cells in two animal models of bone metastasis. Br J Cancer 2008, 98:809-815.
19. Flatt P.R., Bailey C.J. Abnormal plasma glucose and insulin responses in heterozygous lean (ob/+) mice. Diabetologia 1981, 20:573-577.
20. Bouxsein M.L., Boyd S.K., Christiansen B.A., Guldberg R.E., Jepsen K.J., Muller R. Guidelines for assessment of bone microstructure in rodents using micro-computed tomography. J Bone Miner Res 2010, 25:1468-1486.
21. Chappard D., Alexandre C., Riffat G. Histochemical identification of osteoclasts. Review of current methods and reappraisal of a simple procedure for routine diagnosis on undecalcified human iliac bone biopsies. Basic Appl Histochem 1983, 27:75-85.
22. Parfitt A.M., Drezner M.K., Glorieux F.H., Kanis J.A., Malluche H., Meunier P.J., et al. Bone histomorphometry: standardization of nomenclature, symbols, and units. Report of the ASBMR Histomorphometry Nomenclature Committee. J Bone Miner Res 1987, 2:595-610.
23. Mieczkowska A., Basle M.F., Chappard D., Mabilleau G. Thiazolidinediones induce osteocyte apoptosis by a G protein-coupled receptor 40-dependent mechanism. J Biol Chem 2012, 287:23517-23526.
24. Mabilleau G., Chappard D., Sabokbar A. Role of the A20-TRAF6 axis in lipopolysaccharide-mediated osteoclastogenesis. J Biol Chem 2011, 286:3242-3249.
25. Roschger P., Fratzl P., Eschberger J., Klaushofer K. Validation of quantitative backscattered electron imaging for the measurement of mineral density distribution in human bone biopsies. Bone 1998, 23:319-326.
26. Oliver W.C., Pharr G.M. An improved technique for determining hardness and elastic modulus using load and displacement sensing indentation experiments. J Mater Res 1992, 7:1564-1583.
27. Paschalis E.P., DiCarlo E., Betts F., Sherman P., Mendelsohn R., Boskey A.L. FTIR microspectroscopic analysis of human osteonal bone. Calcif Tissue Int 1996, 59:480-487.
28. Paschalis E.P., Verdelis K., Doty S.B., Boskey A.L., Mendelsohn R., Yamauchi M. Spectroscopic characterization of collagen cross-links in bone. J Bone Miner Res 2001, 16:1821-1828.
29. Boskey A.L., DiCarlo E., Paschalis E., West P., Mendelsohn R. Comparison of mineral quality and quantity in iliac crest biopsies from high- and low-turnover osteoporosis: an FT-IR microspectroscopic investigation. Osteoporos Int 2005, 16:2031-2038.
30. Karsenty G., Gershon M.D. The importance of the gastrointestinal tract in the control of bone mass accrual. Gastroenterology 2011, 141:439-442.
31. Yadav V.K., Oury F., Suda N., Liu Z.W., Gao X.B., Confavreux C., et al. A serotonin-dependent mechanism explains the leptin regulation of bone mass, appetite, and energy expenditure. Cell 2009, 138:976-989.
32. Harada N., Yamada Y., Tsukiyama K., Yamada C., Nakamura Y., Mukai E., et al. A novel GIP receptor splice variant influences GIP sensitivity of pancreatic beta-cells in obese mice. Am J Physiol Endocrinol Metab 2008, 294:E61-E68.
33. Gremlich S., Porret A., Hani E.H., Cherif D., Vionnet N., Froguel P., et al. Cloning, functional expression, and chromosomal localization of the human pancreatic islet glucose-dependent insulinotropic polypeptide receptor. Diabetes 1995, 44:1202-1208.
34. Yaqub T., Tikhonova I.G., Lattig J., Magnan R., Laval M., Escrieut C., et al. Identification of determinants of glucose-dependent insulinotropic polypeptide receptor that interact with N-terminal biologically active region of the natural ligand. Mol Pharmacol 2010, 77:547-558.
35. Boylan M.O., Jepeal L.I., Wolfe M.M. Structure of the rat glucose-dependent insulinotropic polypeptide receptor gene. Peptides 1999, 20:219-228.
36. Yamada Y., Hayami T., Nakamura K., Kaisaki P.J., Someya Y., Wang C.Z., et al. Human gastric inhibitory polypeptide receptor: cloning of the gene (GIPR) and cDNA. Genomics 1995, 29:773-776.
37. Shinoda Y., Yamaguchi M., Ogata N., Akune T., Kubota N., Yamauchi T., et al. Regulation of bone formation by adiponectin through autocrine/paracrine and endocrine pathways. J Cell Biochem 2006, 99:196-208.
38. Elefteriou F., Ahn J.D., Takeda S., Starbuck M., Yang X., Liu X., et al. Leptin regulation of bone resorption by the sympathetic nervous system and CART. Nature 2005, 434:514-520.
39. Kajimura D., Hinoi E., Ferron M., Kode A., Riley K.J., Zhou B., et al. Genetic determination of the cellular basis of the sympathetic regulation of bone mass accrual. J Exp Med 2011, 208:841-851.
40. Duvillie B., Cordonnier N., Deltour L., Dandoy-Dron F., Itier J.M., Monthioux E., et al. Phenotypic alterations in insulin-deficient mutant mice. Proc Natl Acad Sci U S A 1997, 94:5137-5140.
41. Fulzele K., Riddle R.C., DiGirolamo D.J., Cao X., Wan C., Chen D., et al. Insulin receptor signaling in osteoblasts regulates postnatal bone acquisition and body composition. Cell 2010, 142:309-319.
42. Pamir N., Lynn F.C., Buchan A.M., Ehses J., Hinke S.A., Pospisilik J.A., et al. Glucose-dependent insulinotropic polypeptide receptor null mice exhibit compensatory changes in the enteroinsular axis. Am J Physiol Endocrinol Metab 2003, 284:E931-E939.
43. Nuche-Berenguer B., Moreno P., Esbrit P., Dapia S., Caeiro J.R., Cancelas J., et al. Effect of GLP-1 treatment on bone turnover in normal, type 2 diabetic, and insulin-resistant states. Calcif Tissue Int 2009, 84:453-461.